<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药通社 | wechat-feeds</title><link>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</link><description>药通社：政策、资讯、产业、技术</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 28 Apr 2021 21:28:24 +0800</pubDate><image><url>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</url><title>药通社 | wechat-feeds</title><link>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>布局医美，加码生物药，华东医药大力升级转型，值得传统药企学习！</title><link>https://mp.weixin.qq.com/s/EehueRgQjaux1wCoYstLrw</link><description></description><content:encoded><![CDATA[布局医美，加码生物药，华东医药大力升级转型，值得传统药企学习！]]></content:encoded><pubDate>Wed, 28 Apr 2021 20:47:27 +0800</pubDate></item><item><title>第三届CMC-China合作伙伴：凌凯、华威、方达、百诚、格林泰科等一大波优质企业已加入，就差你了</title><link>https://mp.weixin.qq.com/s/eV47GxrnMpzT3hQ1Jn8iDw</link><description></description><content:encoded><![CDATA[第三届CMC-China合作伙伴：凌凯、华威、方达、百诚、格林泰科等一大波优质企业已加入，就差你了]]></content:encoded><pubDate>Wed, 28 Apr 2021 20:47:27 +0800</pubDate></item><item><title>BTK抑制剂逆袭！5款新药已上市、1个新品即将出击，BTK抑制剂市场谁领风骚？</title><link>https://mp.weixin.qq.com/s/eEEHln2mV9en_5qZKx9gVg</link><description></description><content:encoded><![CDATA[BTK抑制剂逆袭！5款新药已上市、1个新品即将出击，BTK抑制剂市场谁领风骚？]]></content:encoded><pubDate>Wed, 28 Apr 2021 20:47:27 +0800</pubDate></item><item><title>2020上市药企营收top100出炉：百亿以上有40多家</title><link>https://mp.weixin.qq.com/s/NP04YL5eHJphOBLlYTz6Ug</link><description></description><content:encoded><![CDATA[2020上市药企营收top100出炉：百亿以上有40多家]]></content:encoded><pubDate>Wed, 28 Apr 2021 20:47:27 +0800</pubDate></item><item><title>数百药企，数千职位！老板、HR也要看的制药人才网</title><link>https://mp.weixin.qq.com/s/jyu1kSr_va9fQwrQGQQlzA</link><description></description><content:encoded><![CDATA[数百药企，数千职位！老板、HR也要看的制药人才网]]></content:encoded><pubDate>Wed, 28 Apr 2021 20:47:27 +0800</pubDate></item><item><title>无法采购到原材料，集采中选药物不能正常供应，暂停在线交易</title><link>https://mp.weixin.qq.com/s/cvNwg6tyarxRtj8G8XW23A</link><description></description><content:encoded><![CDATA[无法采购到原材料，集采中选药物不能正常供应，暂停在线交易]]></content:encoded><pubDate>Tue, 27 Apr 2021 22:48:46 +0800</pubDate></item><item><title>药融圈×青松会直播｜全球竞争下中国药企如何把握创新转型大势</title><link>https://mp.weixin.qq.com/s/zChZrGXeQZkc5f1EuJ77jg</link><description></description><content:encoded><![CDATA[药融圈×青松会直播｜全球竞争下中国药企如何把握创新转型大势]]></content:encoded><pubDate>Tue, 27 Apr 2021 22:48:46 +0800</pubDate></item><item><title>最新！NMPA发布41批参比制剂目录！！</title><link>https://mp.weixin.qq.com/s/gJ-dRWs-A61Nk__Hz9-PJg</link><description></description><content:encoded><![CDATA[最新！NMPA发布41批参比制剂目录！！]]></content:encoded><pubDate>Tue, 27 Apr 2021 22:48:46 +0800</pubDate></item><item><title>第三届CMC-China合作伙伴：凌凯、华威、方达、百诚、格林泰科等一大波优质企业已加入，就差你了</title><link>https://mp.weixin.qq.com/s/E6G5VR_M-5rKt0WTXw8hXw</link><description></description><content:encoded><![CDATA[第三届CMC-China合作伙伴：凌凯、华威、方达、百诚、格林泰科等一大波优质企业已加入，就差你了]]></content:encoded><pubDate>Tue, 27 Apr 2021 22:48:46 +0800</pubDate></item><item><title>数百药企，数千职位！老板、HR也要看的制药人才网</title><link>https://mp.weixin.qq.com/s/9Mg1R__eEEYdiwC0hUIKKA</link><description></description><content:encoded><![CDATA[数百药企，数千职位！老板、HR也要看的制药人才网]]></content:encoded><pubDate>Tue, 27 Apr 2021 22:48:46 +0800</pubDate></item><item><title>瞄准医药大数据，药融云西南总部乔迁典礼圆满落幕</title><link>https://mp.weixin.qq.com/s/J3GvniNxnwLSksvjyntuIg</link><description></description><content:encoded><![CDATA[瞄准医药大数据，药融云西南总部乔迁典礼圆满落幕]]></content:encoded><pubDate>Mon, 26 Apr 2021 20:31:57 +0800</pubDate></item><item><title>重磅造影剂，恒瑞-碘克沙醇注射液通过一致性！4.26日共18品规通过一致性！</title><link>https://mp.weixin.qq.com/s/L3bvjhUJde4eTAcaYt4IQg</link><description></description><content:encoded><![CDATA[重磅造影剂，恒瑞-碘克沙醇注射液通过一致性！4.26日共18品规通过一致性！]]></content:encoded><pubDate>Mon, 26 Apr 2021 20:31:57 +0800</pubDate></item><item><title>CDE关于公开征求第二批已上市药品说明书增加儿童用药信息修订意见的通知</title><link>https://mp.weixin.qq.com/s/8y5_sR6MMgB7Hdrs_5uGlQ</link><description></description><content:encoded><![CDATA[CDE关于公开征求第二批已上市药品说明书增加儿童用药信息修订意见的通知]]></content:encoded><pubDate>Mon, 26 Apr 2021 20:31:57 +0800</pubDate></item><item><title>第三届CMC-China合作伙伴：凌凯、华威、方达、百诚、格林泰科等一大波优质企业已加入，就差你了</title><link>https://mp.weixin.qq.com/s/EOXO65dE7v6tUeGHVYrh5Q</link><description></description><content:encoded><![CDATA[第三届CMC-China合作伙伴：凌凯、华威、方达、百诚、格林泰科等一大波优质企业已加入，就差你了]]></content:encoded><pubDate>Mon, 26 Apr 2021 20:31:57 +0800</pubDate></item><item><title>数百药企，数千职位！老板、HR也要看的制药人才网</title><link>https://mp.weixin.qq.com/s/Ef1-LA-4hJidl0lyndC4Sg</link><description></description><content:encoded><![CDATA[数百药企，数千职位！老板、HR也要看的制药人才网]]></content:encoded><pubDate>Mon, 26 Apr 2021 20:31:57 +0800</pubDate></item><item><title>恒瑞榜首！2020上市药企抗肿瘤产品营收top15出炉</title><link>https://mp.weixin.qq.com/s/M7PAeLmybBqDw_0cRdySDA</link><description></description><content:encoded><![CDATA[恒瑞榜首！2020上市药企抗肿瘤产品营收top15出炉]]></content:encoded><pubDate>Mon, 26 Apr 2021 20:31:57 +0800</pubDate></item><item><title>东阳光药业：大品种销量减少，面临集采；积极对奥司他韦进行改良，大力布局新药，前景可期！</title><link>https://mp.weixin.qq.com/s/hMZKy7tMO_a52ucSN5myJA</link><description></description><content:encoded><![CDATA[东阳光药业：大品种销量减少，面临集采；积极对奥司他韦进行改良，大力布局新药，前景可期！]]></content:encoded><pubDate>Sun, 25 Apr 2021 22:10:51 +0800</pubDate></item><item><title>重磅大咖相约金陵：打通新药临床试验痛点堵点，“中国创新药物临床试验PI沙龙”即将开幕</title><link>https://mp.weixin.qq.com/s/HtUWRoUWm_sI75EsGhbg6Q</link><description></description><content:encoded><![CDATA[重磅大咖相约金陵：打通新药临床试验痛点堵点，“中国创新药物临床试验PI沙龙”即将开幕]]></content:encoded><pubDate>Sun, 25 Apr 2021 22:10:51 +0800</pubDate></item><item><title>30位国内外改良新药专家齐聚重庆，盛宴开启</title><link>https://mp.weixin.qq.com/s/ygQmrdaM6UkHGkIq-yrJyQ</link><description></description><content:encoded><![CDATA[30位国内外改良新药专家齐聚重庆，盛宴开启]]></content:encoded><pubDate>Sun, 25 Apr 2021 22:10:51 +0800</pubDate></item><item><title>已上市药品变更备案常见问题解答</title><link>https://mp.weixin.qq.com/s/3NKwztwAfdx3XOWz38FyrA</link><description></description><content:encoded><![CDATA[已上市药品变更备案常见问题解答]]></content:encoded><pubDate>Sun, 25 Apr 2021 22:10:51 +0800</pubDate></item></channel></rss>